TWD 353.5
(2.61%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -680.6 Million TWD | -31.15% |
2022 | -518.96 Million TWD | -5.16% |
2021 | -493.49 Million TWD | 23.24% |
2020 | -642.93 Million TWD | -12.54% |
2019 | -571.28 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -907.66 Million TWD | -33.36% |
2024 Q2 | -1 Billion TWD | -10.54% |
2023 Q1 | -735.71 Million TWD | 0.0% |
2023 Q4 | -680.6 Million TWD | -37.11% |
2023 FY | -680.6 Million TWD | -31.15% |
2023 Q3 | -496.38 Million TWD | 45.9% |
2023 Q2 | -917.6 Million TWD | -24.72% |
2022 FY | -518.96 Million TWD | -5.16% |
2022 Q4 | - TWD | 0.0% |
2021 FY | -493.49 Million TWD | 23.24% |
2020 FY | -642.93 Million TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -157.64% |
Level Biotechnology Inc. | -453.9 Million TWD | -49.945% |
Sagittarius Life Science Corp | -120.57 Million TWD | -464.49% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | -246.546% |
TaiMed Biologics Inc. | 499.84 Million TWD | 236.163% |
GlycoNex Incorporation | -148.56 Million TWD | -358.114% |
VBI | -25.31 Million TWD | -2588.442% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 1790.275% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 593.211% |
Visgeneer Inc. | 31.28 Million TWD | 2275.572% |
Mycenax Biotech Inc. | 207 Million TWD | 428.781% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -406.962% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 209.504% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -1080.419% |
Enimmune corporation | -314.15 Million TWD | -116.644% |
TaiRx, Inc. | -147.86 Million TWD | -360.276% |
CHO Pharma, Inc. | -203.79 Million TWD | -233.971% |
EirGenix Inc. | -4.58 Billion TWD | 85.166% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -702.952% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 663.085% |
Lin BioScience, Inc. | -3.21 Billion TWD | 78.851% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -114.419% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -3335.149% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 2239.665% |
Lukas Biomedical Inc. | 50.75 Million TWD | 1440.963% |
RBC Bioscience Corporation | 422.18 Million TWD | 261.21% |
BiOptic Inc. | 12.59 Million TWD | 5505.067% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 27.933% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -570.64% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -312.049% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 316.153% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -783.399% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -159.198% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 2325.803% |
Neith Corporation | -150.31 Million TWD | -352.799% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -958.14% |
NaviFUS Corp. | -123.12 Million TWD | -452.758% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 1019.104% |
Sinew Pharma Inc. | -160.34 Million TWD | -324.464% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -181.367% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -101.736% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | -64.94% |
AP Biosciences Inc | -196.52 Million TWD | -246.315% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 198.82% |
3D Global Biotech Inc. | -11.43 Million TWD | -5850.914% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 17.969% |
Intech Biopharm Corporation | 1.35 Billion TWD | 150.143% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | -64.05% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -225.123% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -373.093% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -105.906% |
TCI GENE Inc. | -689.25 Million TWD | 1.254% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -472.236% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 48.014% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 3422.785% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -568.112% |
PharmaEngine, Inc. | -860.8 Million TWD | 20.934% |
Savior Lifetec Corporation | -812.54 Million TWD | 16.238% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -126.893% |
OBI Pharma, Inc. | -398.22 Million TWD | -70.91% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | -86.254% |
Acepodia, Inc. | -6.02 Billion TWD | 88.695% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 79.992% |